Painkiller approved for sale in Germany

Company News

by Rachael Jones

Medical Developments International (ASX:MVP) has just announced that Penthrox has been approved for sale in Germany. 

The pain relief medication saw recent approvals in Sweden, Norway, Croatia and Poland. Finland is expected soon.

The CEO says with a population of almost 83 million people in Germany it is the largest spender of healthcare in Europe.

Germany is also the largest user of opioids in Europe. Penthrox is a non-opioid pain relief self-administered with an inhaler.

It has been used safely and effectively for over 40 years in Australia.

Clinical data is still being gathered to submit a new drug application to the Food and Drug Administration in the US.

Shares in Medical Developments International (ASX:MVP) are up 3.28 per cent to $7.24
 

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.